The term 'neuromyelitis optica spectrum disorders'(NMOSD) is used as an umbrella term that
refers to aquaporin-4 immunoglobulin G (AQP4-IgG)-positive neuromyelitis optica (NMO) …

Neuromyelitis optica (NMO) and Neuromyelitis optica spectrum disorders (NMOSD) are a
group of autoimmune conditions characterized by inflammatory involvement of the optic …

Neuromyelitis optica (NMO) is an inflammatory CNS syndrome distinct from multiple
sclerosis (MS) that is associated with serum aquaporin-4 immunoglobulin G antibodies …

The clinical, pathological and therapeutic concepts of NMOSD have evolved and broadened
over the last two decades following the detection of AQP4 antibodies and MOG antibodies in …

Objective: To (1) determine the value of the recently proposed criteria of neuromyelitis optica
(NMO) spectrum disorder (NMOSD) that unify patients with NMO and those with limited …

This manuscript presents practical recommendations for managing acute attacks and
implementing preventive immunotherapies for neuromyelitis optica spectrum disorders …

Neuromyelitis optica (NMO, Devic's syndrome), long considered a clinical variant of multiple
sclerosis, is now regarded as a distinct disease entity. Major progress has been made in the …

Neuromyelitis optica (NMO) is clinically characterized by severe optic neuritis (ON) and
transverse myelitis. NMO spectrum disorder (NMOSD) is anewly emerging disease spectrum …

Objective: To evaluate the application of the 2015 International Panel for NMO Diagnosis
(IPND) criteria to consecutive cases of neuromyelitis optica spectrum disorder (NMOSD) in a …

Neuromyelitis optica (NMO) has long been considered as a variant of multiple sclerosis (MS)
rather than a distinct disease. This concept changed with the discovery of serum antibodies …